| Product NDC: | 59762-5009 |
| Proprietary Name: | clindamycin phosphate |
| Non Proprietary Name: | CLINDAMYCIN PHOSPHATE |
| Active Ingredient(s): | 20 mg/g & nbsp; CLINDAMYCIN PHOSPHATE |
| Administration Route(s): | VAGINAL |
| Dosage Form(s): | CREAM |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 59762-5009 |
| Labeler Name: | Greenstone LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA050680 |
| Marketing Category: | NDA AUTHORIZED GENERIC |
| Start Marketing Date: | 19920811 |
| Package NDC: | 59762-5009-1 |
| Package Description: | 1 TUBE in 1 CARTON (59762-5009-1) > 40 g in 1 TUBE |
| NDC Code | 59762-5009-1 |
| Proprietary Name | clindamycin phosphate |
| Package Description | 1 TUBE in 1 CARTON (59762-5009-1) > 40 g in 1 TUBE |
| Product NDC | 59762-5009 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | CLINDAMYCIN PHOSPHATE |
| Dosage Form Name | CREAM |
| Route Name | VAGINAL |
| Start Marketing Date | 19920811 |
| Marketing Category Name | NDA AUTHORIZED GENERIC |
| Labeler Name | Greenstone LLC |
| Substance Name | CLINDAMYCIN PHOSPHATE |
| Strength Number | 20 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient] |